Please Wait
Applying Filters...
menu
    • menu
    Mix GIF-PSE
    News
    AbbVie to build $1.4B manufacturing campus in North Carolina

    24 Apr 2026

    // PRESS RELEASE

    Merck, Rivals Eye Inhibrx Experimental Drug Tied to Keytruda

    24 Apr 2026

    // REUTERS

    Merck goes with Google for AI push, strikes $1B enterprise deal

    24 Apr 2026

    // PR NEWSWIRE

    DATA COMPILATION
    #PharmaFlow

    #1

    Contact Supplier

    Website

    CPhI China

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cep-q1-2026-update-cep-2-0-edqm-s-new-guidelines-strengthen-ecosystem-indian-firms-top-list-of-ceps-issued
    Menu

    Saiming Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Darolutamide

    02 1Gepotidacin

    03 1Nemonoxacin

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Contact Saiming Pharmaceutical and get a quotation

    Saiming Pharmaceutical is a supplier offers 3 products (APIs, Excipients or Intermediates).

    Find a price of Darolutamide bulk offered by Saiming Pharmaceutical

    Find a price of Gepotidacin bulk offered by Saiming Pharmaceutical

    Find a price of Nemonoxacin bulk offered by Saiming Pharmaceutical

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.